Abstract
Single-nucleotide polymorphisms (SNPs) are common in the human genome, with more than 11 million SNPs having frequencies greater than 1%. The challenge is to identify the minority of functional SNPs from the large number of SNPs that are expected to be silent. Whereas coding variants are unusual, and functional (nonsynonymous) coding SNPs likely rare, regulatory SNPs appear to be common. Traditional methods to identify these SNPs in vitro are time consuming and challenging. An alternative method is to examine the allele-specific expression in the cDNA from tissues expressing the genes of interest and in individuals heterozygous for a transcribed SNP. This method permits expression to be evaluated in the context of the same trans-acting factors and to identify genes with likely cis-acting regulatory variants or parent of origin (imprinting) effects. Such studies require a method to reliably quantify the expression from each allele. Pyrosequencing offers such capabilities, and given the relatively low cost and high throughput, it offers a sensitive method to determine allelic imbalance in the cDNA from tissues expressing genes of interest.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Cheung, V. G., Spielman, R. S., Ewens, K. G., et al. (2005) Mapping determinants of human gene expression by regional and genome-wide association. Nature 437, 1365–1369.
Monks, S. A., Leonardson, A., Zhu, H., et al. (2004) Genetic inheritance of gene expression in human cell lines. Am. J. Hum. Genet. 75, 1094–1105.
Farh, K. K., Grimson, A., Jan, C., et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310, 1817–1821.
Bento J. L., Palmer, N. D., Mychaleckyj, J. C., et al. (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53, 3007–3012.
Grant, S. F., Thorleifsson, G., Reynisdottir, I., et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320–323.
Horikawa, Y., Oda, N., Cox, N. J., et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26, 163–175.
Mohlke, K. L. and Boehnke, M. (2005) The role of HNF4A variants in the risk of type 2 diabetes. Curr. Diab. Rep. 5, 149–156.
Ben Asher, E. and Lancet, D. (2004) 5-Lipoxygenase activating protein (ALOX5AP): association with cardiovascular infarction and stroke. Isr. Med. Assoc. J. 6, 318–319.
Helgadottir, A., Manolescu, A., Thorleifsson, G., et al. (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233–239.
Helgadottir, A., Manolescu, A., Thorleifsson, G., et al. (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233–239.
Sayers, I., Barton, S., Rorke, S., et al. (2003) Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin. Exp. Allergy 33, 1103–1110.
Van Eerdewegh, P., Little, R. D., Dupuis, J., et al. (2002) Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418, 426–430.
Vermeire, S. and Rutgeerts, P. (2005) Current status of genetics research in inflammatory bowel disease. Genes Immun. 6, 637–645.
Baier, L. J., Permana, P. A., Yang, X., et al. (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 106, R69–R73.
Yan, H., Yuan, W., Velculescu, V. E., et al. (2002) Allelic variation in human gene expression. Science 297, 1143.
Morley, M., Molony, C. M., Weber, T. M., et al. (2004) Genetic analysis of genome-wide variation in human gene expression. Nature 430, 743–747.
Stranger, B. E., Forrest, M. S., Clark, A. G., et al. (2005) Genome-wide associations of gene expression variation in humans. PLoS. Genet. 1, e78.
Buckland, P. R. (2005) The importance and identification of regulatory polymorphisms and their mechanisms of action. Biochim. Biophys. Acta. 1762, 17–28.
Pastinen, T., Sladek, R., Gurd, S., et al. (2004) A survey of genetic and epigenetic variation affecting human gene expression. Physiol. Genomics 16, 184–193.
Wang, H., Zhang, H., Jia, Y., et al. (2004) Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance. Diabetes 53, 2132–2136.
Wang, H., Zhang, Z., Chu, W., et al. (2005) Molecular screening and association analyses of the interleukin 6 receptor gene variants with type 2 diabetes, diabetic nephropathy, and insulin sensitivity. J. Clin. Endocrinol. Metab. 90, 1123–1129.
Bray, N. J., Buckland, P. R., Owen, M. J., et al. (2003) Cis-acting variation in the expression of a high proportion of genes in human brain. Hum. Genet. 113, 149–153.
Lo, H. S., Wang, Z., Hu, Y., et al. (2003) Allelic variation in gene expression is common in the human genome. Genome Res. 13, 1855–1862.
Ge, B., Gurd, S., Gaudin, T., et al. (2005) Survey of allelic expression using EST mining. Genome Res. 15, 1584–1591.
Knight, J. C., Keating, B. J., Rockett, K. A., et al. (2003) In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat. Genet. 33, 469–475.
Das, S. K., Chu, W., Zhang, Z., et al. (2004) Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians. Diabetes 53, 3300–3306.
Elbein, S. C., Zheng, H., Jia, Y., et al. (2004) Molecular screening of the human glutamine-fructose-6-phosphate amidotransferase 1 (GFPT1) gene and association studies with diabetes and diabetic nephropathy. Mol. Genet. Metab. 82, 321–328.
Zhang, H., Jia, Y., Cooper, J. J., et al. (2004) Common variants in glutamine:fructose-6-phosphate amidotransferase 2 (GFPT2) gene are associated with type 2 diabetes, diabetic nephropathy, and increased GFPT2 mRNA levels. J. Clin. Endocrinol. Metab. 89, 748–755.
Sun, A., Ge, J., Siffert, W., et al. (2005) Quantification of allele-specific G-protein beta3 subunit mRNA transcripts in different human cells and tissues by Pyrosequencing. Eur. J. Hum. Genet. 13, 361–369.
Gruber, J. D., Colligan, P. B., and Wolford, J. K. (2002) Estimation of single nucleotide polymorphism allele frequency in DNA pools by using Pyrosequencing. Hum. Genet. 110, 395–401.
Wasson, J., Skolnick, G., Love-Gregory, L., et al. (2002) Assessing allele frequencies of single nucleotide polymorphisms in DNA pools by Pyrosequencing technology. BioTechniques 32, 1144–1150.
Pastinen, T., Ge, B., Gurd S., et al. (2005) Mapping common regulatory variants to human haplotypes. Hum. Mol. Genet. 14, 3963–3971.
Gabriel, S. B., Schaffner, S. F., Nguyen, H., et al. (2002) The structure of haplotype blocks in the human genome. Science 296, 2225–2229.
Gibbs, R. A., Belmont, J. W., Hardenbol, P., et al. (2003) The International HapMap Project. Nature 426, 789–796.
Xie, X., Lu, J., Kulbokas, E. J., et al. (2005) Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434, 338–345.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Wang, H., Elbein, S.C. (2007). Detection of Allelic Imbalance in Gene Expression Using Pyrosequencing®. In: Walker, J.M., Marsh, S. (eds) Pyrosequencing® Protocols. Methods in Molecular Biology™, vol 373. Humana Press. https://doi.org/10.1385/1-59745-377-3:157
Download citation
DOI: https://doi.org/10.1385/1-59745-377-3:157
Publisher Name: Humana Press
Print ISBN: 978-1-58829-645-0
Online ISBN: 978-1-59745-377-6
eBook Packages: Springer Protocols